The office will employ in the region 30 to 40 people by the end of 2006, with research activities related to clinical R&D also managed from Ireland. The second stage of development may include construction of a manufacturing facility in the country.
“The opening of our European headquarters is a seminal milestone for Nabi Biopharmaceuticals,” stated Thomas McLain, chairman, CEO and president of Nabi. “By building an infrastructure in Europe, we will be able to readily advance our strategic initiatives in our key markets and grow our leadership position in nephrology and other target areas.”
Dick Roche, Minister for the Environment, Heritage and Local Government, commented, “This is the first full-scale European headquarters to be established by a US biopharmaceutical company in Ireland, and I am confident that this decision by Nabi Biopharmaceuticals will encourage many others to follow. This type of investment is pivotal to the continued development of Ireland’s knowledge economy.”
Ireland has attracted many of the world’s leading companies and is now home to 13 of the top 15 pharmaceutical companies.